Unity Biotechnology's market cap is currently $40.10M. The company's EPS TTM is $-1.319; its P/E ratio is ―; Unity Biotechnology is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 236.00K	$ 4.78M	$ 0.00	$ 0.00
Gross Profit	$ -19.70M	$ -1.94M	$ 1.90M	$ -3.45M	$ -2.66M
Operating Income	$ -44.67M	$ -57.57M	$ -56.66M	$ -93.93M	$ -89.65M
EBITDA	$ -37.28M	$ -38.73M	$ -54.67M	$ -89.10M	$ -89.65M
Net Income	$ -39.86M	$ -57.75M	$ -60.04M	$ -91.87M	$ -74.87M
Balance Sheet
Cash & Short-Term Investments	$ 43.20M	$ 94.80M	$ 88.08M	$ 97.70M	$ 127.49M
Total Assets	$ 65.69M	$ 124.35M	$ 124.71M	$ 156.32M	$ 151.22M
Total Debt	$ 26.99M	$ 47.36M	$ 51.56M	$ 58.98M	$ 45.00K
Net Debt	$ 7.19M	$ 34.62M	$ 18.65M	$ 41.17M	$ -37.43M
Total Liabilities	$ 37.29M	$ 57.50M	$ 65.14M	$ 73.44M	$ 30.51M
Stockholders' Equity	$ 28.40M	$ 66.85M	$ 59.57M	$ 82.88M	$ 120.71M
Cash Flow
Free Cash Flow	$ -37.10M	$ -51.13M	$ -45.26M	$ -78.98M	$ -74.01M
Operating Cash Flow	$ -38.65M	$ -51.03M	$ -45.06M	$ -78.33M	$ -72.42M
Investing Cash Flow	$ 60.49M	$ -24.55M	$ 39.31M	$ -5.21M	$ 67.95M
Financing Cash Flow	$ -16.34M	$ 54.85M	$ 20.84M	$ 63.88M	$ 27.44M

Currency in USD

Unity Biotechnology Earnings and Revenue History

Income Statement >

Unity Biotechnology Debt to Assets

Balance Sheet >

Unity Biotechnology Cash Flow

Cash Flow >

Unity Biotechnology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing